Status:

ACTIVE_NOT_RECRUITING

Clinical Investigation Evaluating the Safety and Feasibility of Adipearl

Lead Sponsor:

Volumina Medical S.A.

Conditions:

Mid-face Volume Deficiency

Eligibility:

All Genders

22-65 years

Phase:

NA

Brief Summary

Adipearl is an injectable filler intended to be injected subcutaneously in the face.

Eligibility Criteria

Inclusion

  • Subject having given freely and expressly informed consent;
  • Subject deemed by the Investigator to be medically fit for injection of the product;
  • Female or male subjects aged 22 to 65 years (inclusive);

Exclusion

  • Pregnant or nursing woman or planning a pregnancy during the study.
  • Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
  • Subject participating to another research study.
  • Subject with the presence of any condition, which in the opinion of the Principal Investigator, that makes her/him unable to complete the study per protocol.

Key Trial Info

Start Date :

November 25 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT06034522

Start Date

November 25 2023

End Date

November 1 2026

Last Update

September 23 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Art Clinic

Stockholm, Sweden